
Using a cost-utility model of a hypothetical group of symptomatic children aged younger than 2 years who were diagnosed with acute otitis media (AOM), investigators evaluated whether antimicrobial therapy reduces time to symptom resolution, overall symptom burden, and persistence of infection.
